Blam Oren Gil MD is categorized under Rehabilitation Center, Outpatient Treatment in Halethorpe, MD and active since 2009.
Blam Oren Gil MD was established in 2009, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Rehabilitation Center, Outpatient Treatment business, which does work in the B2C market, and is classified as a Rehabilitation Center, Outpatient Treatment, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Oren Gil Blam at the company’s single location by writing to 3421 Benson Avenue # 100, Halethorpe, Maryland MD 21227 or by phoning (410) 644-1880. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Blam Oren Gil MD |
Contact Person: | Oren Gil Blam |
Address: | 3421 Benson Avenue # 100, Halethorpe, Maryland 21227 |
Phone Number: | (410) 644-1880 |
Annual Revenue (USD): | $500.000 to $999.999 |
Founded: | 2009 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Rehabilitation Center, Outpatient Treatment |
SIC Code: | 8093 |
NAICS Code: | 6211110 |
Share This Business: |
Blam Oren Gil MD was started in 2009 to provide professional Rehabilitation Center, Outpatient Treatment under the SIC code 8093 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Oren Gil Blam for inquiries that concern Blam Oren Gil MD by calling the company number (410) 644-1880, as your correspondence is most welcome. Additionally, the physical location of the single location of Blam Oren Gil MD can be found at the coordinates 39.26724,-76.67146 as well as the street address 3421 Benson Avenue # 100 in Halethorpe, Maryland 21227.
For its online presence, you may visit Blam Oren Gil MD’s website at and engage with its social media outlets through on Twitter and on Facebook.